The findings from a team led by Agnieszka Witkiewicz, MD, and Erik Knudsen, PhD, at Roswell Park Comprehensive Cancer Center and published today in the journal Gut suggest a combination treatment approach that can make some breakthrough immunotherapy drugs effective for more patients with pancreatic cancer.
The study opens up a possibility for improving outcomes for patients with a notoriously difficult-to-treat cancer using a combination of existing drugs. Read more . . .